id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-M-6984-0002,FDA,FDA-2017-M-6984,"Medical Devices; Availability of Safety and Effectiveness Summaries for
Premarket Approval Applications",Notice,Notice of Publication,2018-11-16T05:00:00Z,2018,11,2018-11-16T05:00:00Z,,2018-11-16T16:17:27Z,2018-25071,0,0,09000064838dffb3
FDA-2017-M-6984-0001,FDA,FDA-2017-M-6984,"Premarket Approval Response from FDA CDRH to Medtronic, Inc. Implantable System for Remodulin",Other,Letter(s),2018-02-05T05:00:00Z,2018,2,2018-02-05T05:00:00Z,,2018-02-05T14:37:37Z,,0,0,0900006482eeaa8b